Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
[324 Pages Report] The global endoscopic retrograde cholangiopancreatography (ERCP) devices market is estimated to reach US$ 1.5 Billion in 2022, and anticipated to reach US$ 2.8 Bn by 2032, owing to an increase in cancer cases across the globe. As per FMI, the endoscopic retrograde cholangiopancreatography (ERCP) devices market is likely to exhibit the growth at a CAGR of 6.2% during the forecast period from 2022 to 2032.
Report Attribute | Details |
---|---|
Endoscopic Retrograde Cholangiopancreatography Devices Market Anticipated Forecast Value (2022) | US$ 1.5 Billion |
Endoscopic Retrograde Cholangiopancreatography Devices Market Anticipated Forecast Value (2032) | US$ 2.8 Billion |
Endoscopic Retrograde Cholangiopancreatography Devices Market Projected Growth Rate (2022 to 2032) | 6.2% CAGR |
Endoscopic retrograde cholangiopancreatography (ERCP) device is a mixed fluoroscopic and endoscopic procedure wherein an endoscope is introduced into the second part of the duodenum, therefore enabling other tools to be incorporated into the biliary and pancreatic ducts through the key duodenal papilla.
ERCP devices use an amalgamation of luminal endoscopy and fluoroscopic imaging to diagnose and treat disorders related to pancreaticobiliary. These devices make use of a side-view duodenoscopy and are introduced through the esophagus and stomach into the stomach section of the duodenum. Endoscopic retrograde cholangiopancreatography (ERCP) devices are mainly used for extracting samples of cells and tissues or for treating blocked bile or pancreatic duct.
Substitutes for ERCP devices consist of magnetic resonance cholangiopancreatography devices and computed tomography machines, and therefore there is a strong demand for endoscopic retrograde cholangiopancreatography devices in the coming years.
The market is majorly driven by increasing cancer cases, added investments by governments and healthcare facilities to enhance endoscopy research, rising adoption of minimally invasive procedures and surgeries, and major hospitals investing in improved endoscopy research.
The COVID-19 pandemic has adversely affected all industries across the globe. Surgeons and patients who visited hospitals for varied treatments were at a higher risk of getting infected by the virus. Several gastrointestinal procedures were halted or stopped, and this led to reduced device-based treatments such as ERCP.
Based on research, the pandemic considerably decreased ERCP procedures. Approximately 50 per cent of endoscopy procedures were annulled in several primary hospitals across Germany. In the UK and worldwide, the success rate diminished owing to restrictions on endoscopic services.
All these factors adversely affected the endoscopic retrograde cholangiopancreatography (ERCP) devices market. Furthermore, the endoscopy procedure is believed to be a procedure that generates aerosol; this possessed as a threat and risk of transmission to healthcare professionals.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The growth of the Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices market is attributed to the rising number of cancer cases and a paradigm shift toward minimally invasive procedures.
Several other factors such as an increase in incidences of chronic biliary and gastrointestinal disorders like colitis, Barrett’s disease, Crohn’s disease, biliary disease, pancreatitis, gastroesophageal reflux disorder (GERD), peptic ulcer disease, liver disease, and inflammatory bowel disease, support the demand for endoscopic retrograde cholangiopancreatography (ERCP) devices and thereby contribute to the higher growth rate of the ERCP devices market.
There is a swift rise in the frequencies of benign tumours of the pancreas and liver along with the rising geriatric population, which contributes to the market growth of endoscopic retrograde cholangiopancreatography (ERCP) devices.
Additionally, there is more awareness pertaining to the devices which are used in ERCP for treating disorders. Currently, there is various ongoing research done towards safer use and enhanced efficiency of these endoscopic retrograde cholangiopancreatography (ERCP) devices. This, coupled with increasing government support for R&D, could fuel the market growth for endoscopic retrograde cholangiopancreatography (ERCP) devices throughout the forecast period
Amongst the economies across the world, the swiftest growing ones are Brazil, Russia, India, China, and South Africa (BRICS). As per the World Economic Forum, the developing economies attributed for nearly one-third of the worldwide expenditure in 2021.
Over half of the world’s population resides in China and India, and this makes their countries with the highest patient population. The fastest enhancements in healthcare infrastructure, rising burden of cancer, existence of flexible regulation, and speedy growth in medical tourism in these emerging countries promotes market players in the endoscopy equipment market to bloom their footprint in these countries.
Various manufacturers of endoscopy equipment are presently setting up their facilities in Latin America, Asia Pacific, and the Middle East. For instance, giants like Karl Storz have established their R&D and manufacturing facilities in these countries.
Moreover, in the developed regions, market saturation is observed. Therefore, in regions like Europe and North America, manufacturers are forced to focus more on emerging market in the future years. All these abovementioned are projected to render considerable growth opportunities for the ERCP market.
ERCP devices and procedures are expensive, and therefore the high costs pertaining to the treatment from ERCP are one of the key factors hampering the market growth and hence the demand for endoscopic retrograde cholangiopancreatography (ERCP) devices.
Also, the risks and side-effects of the treatment procedure like post-ERCP pancreatitis are anticipated to hinder the growth of the market during the forecast period. Furthermore, for several small-scale end users, these procure are not easily accessible and are not affordable.
Region-wise, North America's Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices market is projected to bloom considerably due to a greater number of research related to diagnostic imaging and improved R&D for novel upgraded ERCP devices.
In 2019, North America accounted for a larger market share owing to the well-established healthcare infrastructure in this region and the existence of key players and their product availability. Excess expenditure and enhanced healthcare infrastructure are projected to boost the Europe market for ERCP devices during the forecast period.
Nevertheless, Asia Pacific is said to garner higher CAGR since several governments of the countries from this region are focusing on investing in the development of healthcare infrastructure.
Also, increasing awareness about cholangiopancreatography procedures in Japan, China and India will promote the growth of the market in the Asia Pacific. Additionally, in 2021, China and Japan attributed for nearly 60% market share at the regional level, owing to increased cases of Gastrointestinal cancers in both these countries.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the most prominent companies in the global endoscopic retrograde cholangiopancreatography (ERCP) devices market are Olympus Corporation, Boston Scientific Corporation, CONMED Corporation, Cook Medical, Inc., Fujifilm Holdings Corporation, Hobbs Medical, Merit Medical Systems and, TeleMed Systems, Inc.
Recently, the manufacturers operating in the endoscopic retrograde cholangiopancreatography (ERCP) devices have been engaged in novel product launches, acquisitions, and partnerships, to gain considerable position in the market. For example, Fujifilm Holdings Corporation in March 2021 acquired the diagnostic imaging-related business of Hitachi Ltd., to make its healthcare business more robust.
Report Attribute | Details |
---|---|
Growth rate | CAGR of 6.2% from 2022 to 2032 |
Base year for estimation | 2021 |
Historical data | 2015 to 2020 |
Forecast period | 2022 to 2032 |
Quantitative units | Revenue in USD million, volume in kilotons, and CAGR from 2022 to 2032 |
Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis |
Segments covered | Disease Indication, Product Type, End User, Region |
Regional scope | North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand |
Country scope | USA; Canada; Mexico; Germany; UK; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
Key companies profiled | Olympus Corporation, Boston Scientific Corporation, CONMED Corporation, Cook Medical, Inc., Hobbs Medical, Merit Medical Systems and, TeleMed Systems, Inc., Fujifilm Holdings Corporation |
Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
The global endoscopic retrograde cholangiopancreatography (ERCP) devices market is estimated to grow at a CAGR of 6.2% from 2022 to 2032.
North America is the key region accountable for highest revenue generation in this market.
Some of the key players in the market include Olympus Corporation, Boston Scientific Corporation, CONMED Corporation, Cook Medical, Inc., Hobbs Medical, Merit Medical Systems and, Fujifilm Holdings Corporation, TeleMed Systems, Inc.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Disease Indication 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Disease Indication, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Disease Indication, 2022-2032 5.3.1. Gastroesophageal Reflux Disease 5.3.2. GI Cancer 5.3.3. Barrett's Esophagus 5.3.4. Bile Duct Diseases 5.3.5. Peptic Ulcer Disease 5.3.6. Crohn's Disease 5.3.7. Intestinal Pseudo-Obstruction and Ogilvie Syndrome 5.3.8. Other Disease Indications 5.4. Y-o-Y Growth Trend Analysis By Disease Indication, 2017-2021 5.5. Absolute $ Opportunity Analysis By Disease Indication, 2022-2032 6. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product Type, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product Type, 2022-2032 6.3.1. Sphincterotomes 6.3.2. Lithotripter 6.3.3. Endoscopes 6.3.4. Accessories 6.3.5. Stents 6.3.6. Cannulas 6.3.7. Forceps 6.3.8. Snares 6.3.9. Catheters 6.3.10. Guiding Wires 6.3.11. Balloons 6.3.12. Others (Baskets etc.) 6.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021 6.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032 7. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast 2022-2032, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End User, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End User, 2022-2032 7.3.1. Hospitals 7.3.2. Specialty Clinics 7.3.3. Diagnostic Laboratories 7.3.4. Others 7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021 7.5. Absolute $ Opportunity Analysis By End User, 2022-2032 8. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021 8.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. East Asia 8.3.5. South Asia & Pacific 8.3.6. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Disease Indication 9.2.3. By Product Type 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Disease Indication 9.3.3. By Product Type 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Mexico 10.2.1.2. Brazil 10.2.1.3. Rest of Latin America 10.2.2. By Disease Indication 10.2.3. By Product Type 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Disease Indication 10.3.3. By Product Type 10.3.4. By End User 10.4. Key Takeaways 11. Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. Italy 11.2.1.3. France 11.2.1.4. U.K. 11.2.1.5. Spain 11.2.1.6. BENELUX 11.2.1.7. Russia 11.2.1.8. Rest of Europe 11.2.2. By Disease Indication 11.2.3. By Product Type 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Disease Indication 11.3.3. By Product Type 11.3.4. By End User 11.4. Key Takeaways 12. East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.2. By Disease Indication 12.2.3. By Product Type 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Disease Indication 12.3.3. By Product Type 12.3.4. By End User 12.4. Key Takeaways 13. South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. India 13.2.1.2. ASEAN 13.2.1.3. Australia and New Zealand 13.2.1.4. Rest of South Asia & Pacific 13.2.2. By Disease Indication 13.2.3. By Product Type 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Disease Indication 13.3.3. By Product Type 13.3.4. By End User 13.4. Key Takeaways 14. MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country 14.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021 14.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. Turkey 14.2.1.3. South Africa 14.2.1.4. Rest of MEA 14.2.2. By Disease Indication 14.2.3. By Product Type 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Disease Indication 14.3.3. By Product Type 14.3.4. By End User 14.4. Key Takeaways 15. Key Countries Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Analysis 15.1. U.S. 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2021 15.1.2.1. By Disease Indication 15.1.2.2. By Product Type 15.1.2.3. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2021 15.2.2.1. By Disease Indication 15.2.2.2. By Product Type 15.2.2.3. By End User 15.3. Mexico 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2021 15.3.2.1. By Disease Indication 15.3.2.2. By Product Type 15.3.2.3. By End User 15.4. Brazil 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2021 15.4.2.1. By Disease Indication 15.4.2.2. By Product Type 15.4.2.3. By End User 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2021 15.5.2.1. By Disease Indication 15.5.2.2. By Product Type 15.5.2.3. By End User 15.6. Italy 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2021 15.6.2.1. By Disease Indication 15.6.2.2. By Product Type 15.6.2.3. By End User 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2021 15.7.2.1. By Disease Indication 15.7.2.2. By Product Type 15.7.2.3. By End User 15.8. U.K. 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2021 15.8.2.1. By Disease Indication 15.8.2.2. By Product Type 15.8.2.3. By End User 15.9. Spain 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2021 15.9.2.1. By Disease Indication 15.9.2.2. By Product Type 15.9.2.3. By End User 15.10. BENELUX 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2021 15.10.2.1. By Disease Indication 15.10.2.2. By Product Type 15.10.2.3. By End User 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2021 15.11.2.1. By Disease Indication 15.11.2.2. By Product Type 15.11.2.3. By End User 15.12. China 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2021 15.12.2.1. By Disease Indication 15.12.2.2. By Product Type 15.12.2.3. By End User 15.13. Japan 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2021 15.13.2.1. By Disease Indication 15.13.2.2. By Product Type 15.13.2.3. By End User 15.14. South Korea 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2021 15.14.2.1. By Disease Indication 15.14.2.2. By Product Type 15.14.2.3. By End User 15.15. India 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2021 15.15.2.1. By Disease Indication 15.15.2.2. By Product Type 15.15.2.3. By End User 15.16. ASEAN 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2021 15.16.2.1. By Disease Indication 15.16.2.2. By Product Type 15.16.2.3. By End User 15.17. Australia and New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2021 15.17.2.1. By Disease Indication 15.17.2.2. By Product Type 15.17.2.3. By End User 15.18. GCC Countries 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2021 15.18.2.1. By Disease Indication 15.18.2.2. By Product Type 15.18.2.3. By End User 15.19. Turkey 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2021 15.19.2.1. By Disease Indication 15.19.2.2. By Product Type 15.19.2.3. By End User 15.20. South Africa 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2021 15.20.2.1. By Disease Indication 15.20.2.2. By Product Type 15.20.2.3. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Disease Indication 16.3.3. By Product Type 16.3.4. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Olympus Corporation 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. Boston Scientific Corporation 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. CONMED Corporation 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. Cook Medical, Inc. 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. Hobbs Medical 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. Merit Medical Systems 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. TeleMed Systems, Inc. 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Table 1: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Region, 2017-2032 Table 2: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Region, 2017-2032 Table 3: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032 Table 4: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Disease Indication, 2017-2032 Table 5: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 6: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Product Type, 2017-2032 Table 7: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 8: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by End User, 2017-2032 Table 9: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 10: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Country, 2017-2032 Table 11: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032 Table 12: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Disease Indication, 2017-2032 Table 13: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 14: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Product Type, 2017-2032 Table 15: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 16: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by End User, 2017-2032 Table 17: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 18: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Country, 2017-2032 Table 19: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032 Table 20: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Disease Indication, 2017-2032 Table 21: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 22: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Product Type, 2017-2032 Table 23: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 24: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by End User, 2017-2032 Table 25: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 26: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Country, 2017-2032 Table 27: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032 Table 28: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Disease Indication, 2017-2032 Table 29: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 30: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Product Type, 2017-2032 Table 31: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 32: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by End User, 2017-2032 Table 33: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 34: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Country, 2017-2032 Table 35: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032 Table 36: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Disease Indication, 2017-2032 Table 37: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 38: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Product Type, 2017-2032 Table 39: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 40: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by End User, 2017-2032 Table 41: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 42: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Country, 2017-2032 Table 43: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032 Table 44: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Disease Indication, 2017-2032 Table 45: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 46: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Product Type, 2017-2032 Table 47: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 48: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by End User, 2017-2032 Table 49: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 50: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Country, 2017-2032 Table 51: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Disease Indication, 2017-2032 Table 52: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Disease Indication, 2017-2032 Table 53: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 54: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by Product Type, 2017-2032 Table 55: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 56: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Forecast by End User, 2017-2032
Figure 1: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Disease Indication, 2022-2032 Figure 2: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Product Type, 2022-2032 Figure 3: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by End User, 2022-2032 Figure 4: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Region, 2022-2032 Figure 5: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Region, 2017-2032 Figure 6: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Region, 2017-2032 Figure 7: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Region, 2022-2032 Figure 8: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Region, 2022-2032 Figure 9: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032 Figure 10: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Disease Indication, 2017-2032 Figure 11: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032 Figure 12: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032 Figure 13: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 14: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Product Type, 2017-2032 Figure 15: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 16: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 17: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 18: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by End User, 2017-2032 Figure 19: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 20: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 21: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Disease Indication, 2022-2032 Figure 22: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Product Type, 2022-2032 Figure 23: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by End User, 2022-2032 Figure 24: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Region, 2022-2032 Figure 25: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Disease Indication, 2022-2032 Figure 26: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Product Type, 2022-2032 Figure 27: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by End User, 2022-2032 Figure 28: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Country, 2022-2032 Figure 29: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 30: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Country, 2017-2032 Figure 31: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 32: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 33: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032 Figure 34: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Disease Indication, 2017-2032 Figure 35: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032 Figure 36: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032 Figure 37: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 38: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Product Type, 2017-2032 Figure 39: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 40: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 41: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 42: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by End User, 2017-2032 Figure 43: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 44: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 45: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Disease Indication, 2022-2032 Figure 46: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Product Type, 2022-2032 Figure 47: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by End User, 2022-2032 Figure 48: North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Country, 2022-2032 Figure 49: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Disease Indication, 2022-2032 Figure 50: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Product Type, 2022-2032 Figure 51: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by End User, 2022-2032 Figure 52: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Country, 2022-2032 Figure 53: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 54: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Country, 2017-2032 Figure 55: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 56: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 57: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032 Figure 58: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Disease Indication, 2017-2032 Figure 59: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032 Figure 60: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032 Figure 61: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 62: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Product Type, 2017-2032 Figure 63: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 64: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 65: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 66: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by End User, 2017-2032 Figure 67: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 68: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 69: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Disease Indication, 2022-2032 Figure 70: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Product Type, 2022-2032 Figure 71: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by End User, 2022-2032 Figure 72: Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Country, 2022-2032 Figure 73: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Disease Indication, 2022-2032 Figure 74: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Product Type, 2022-2032 Figure 75: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by End User, 2022-2032 Figure 76: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Country, 2022-2032 Figure 77: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 78: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Country, 2017-2032 Figure 79: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 80: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 81: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032 Figure 82: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Disease Indication, 2017-2032 Figure 83: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032 Figure 84: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032 Figure 85: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 86: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Product Type, 2017-2032 Figure 87: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 88: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 89: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 90: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by End User, 2017-2032 Figure 91: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 92: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 93: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Disease Indication, 2022-2032 Figure 94: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Product Type, 2022-2032 Figure 95: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by End User, 2022-2032 Figure 96: Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Country, 2022-2032 Figure 97: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Disease Indication, 2022-2032 Figure 98: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Product Type, 2022-2032 Figure 99: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by End User, 2022-2032 Figure 100: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Country, 2022-2032 Figure 101: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 102: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Country, 2017-2032 Figure 103: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 104: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 105: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032 Figure 106: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Disease Indication, 2017-2032 Figure 107: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032 Figure 108: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032 Figure 109: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 110: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Product Type, 2017-2032 Figure 111: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 112: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 113: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 114: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by End User, 2017-2032 Figure 115: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 116: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 117: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Disease Indication, 2022-2032 Figure 118: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Product Type, 2022-2032 Figure 119: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by End User, 2022-2032 Figure 120: East Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Country, 2022-2032 Figure 121: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Disease Indication, 2022-2032 Figure 122: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Product Type, 2022-2032 Figure 123: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by End User, 2022-2032 Figure 124: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Country, 2022-2032 Figure 125: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 126: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Country, 2017-2032 Figure 127: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 128: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 129: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032 Figure 130: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Disease Indication, 2017-2032 Figure 131: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032 Figure 132: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032 Figure 133: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 134: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Product Type, 2017-2032 Figure 135: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 136: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 137: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 138: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by End User, 2017-2032 Figure 139: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 140: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 141: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Disease Indication, 2022-2032 Figure 142: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Product Type, 2022-2032 Figure 143: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by End User, 2022-2032 Figure 144: South Asia & Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Country, 2022-2032 Figure 145: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Disease Indication, 2022-2032 Figure 146: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Product Type, 2022-2032 Figure 147: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by End User, 2022-2032 Figure 148: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) by Country, 2022-2032 Figure 149: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 150: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Country, 2017-2032 Figure 151: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 152: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 153: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Disease Indication, 2017-2032 Figure 154: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Disease Indication, 2017-2032 Figure 155: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Disease Indication, 2022-2032 Figure 156: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Disease Indication, 2022-2032 Figure 157: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 158: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by Product Type, 2017-2032 Figure 159: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 160: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 161: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 162: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Volume (Units) Analysis by End User, 2017-2032 Figure 163: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 164: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 165: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Disease Indication, 2022-2032 Figure 166: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Product Type, 2022-2032 Figure 167: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by End User, 2022-2032 Figure 168: MEA Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Attractiveness by Country, 2022-2032
Recommendations
Explore Healthcare Insights
View Reports